News

News-Medical.Net on MSN3d
Basal ganglia neurons precisely regulate complex movement timing
Neurons deep in the brain not only help to initiate movement-they also actively suppress it, and with astonishing precision.
A central switchboard: Neurons deep in the brain act as a movement 'brake'
Neurons deep in the brain not only help to initiate movement—they also actively suppress it, and with astonishing precision.
Labroots5d
CRISPR Reveals Mitochondrial Dysfunction Underlying ALS
The CRISPR gene editing tool has been revolionary for the research lab, and it has also been used to transform the lives ... | Genetics And Genomics ...
GEN - Genetic Engineering and Biotechnology News4d
Several ALS Patients See Remarkable Response to ASO Treatment
Typically, the goal of ALS treatments is to slow the disease or halt progression. But new data from the antisense oligonucleotide (ASO) jacifusen for FUS-ALS show that two patients went beyond the ...
Science Daily4d
A switchboard with precision: How the brain licenses movements
Neurons deep in the brain not only help to initiate movement -- they also actively suppress it, and with astonishing precision. The findings are especially relevant for better understanding ...
The Manila Times2d
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated ...
Understanding one gene's role in different neurodevelopmental disorders
Researchers have identified how variations in a gene called TRIO can influence brain functions and result in distinct ...
Fact check: RFK Jr. denies cuts to scientific research while slashing staff, funding
Under the Trump administration, the Department of Health and Human Services has canceled or frozen billions of ...
Contact training ‘a potential killer’, US scientist warns
The AFL has been urged to “get its head out of the sand” and immediately eliminate unnecessary full contact training to make ...
CorestemChemon Inc.: Neuronata-R Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- ...